InsidersTradesSigma
AstraZeneca PLC: directors' dealings · Finland · FIN-FSA
FI:astrazeneca-plcUS0463531089FI·FIN-FSAMcap 2665.9Bn€Healthcare
Explore the full management transaction log of AstraZeneca PLC, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, AstraZeneca PLC has logged 13 public disclosures. Market capitalisation: €2,665.9bn. The latest transaction was disclosed on 18 August 2025 (Sale). Among the most active insiders: Pascal Soriot. All data is openly available.
13
Insider Decl.
0
Thresholds
€24m
8 ops.
Buy Volume
€1m
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1719.00 €
Analyst consensus
3 analysts1666.98 €Target 1854.99 €(+8%)1970.06 €
Income statement
Revenue58.74 Bn€
Gross profit48.11 Bn€82% margin
Net income10.22 Bn€17.2% margin
Valuation
PER (trailing)27.7x
PER (forward)151.5x
P/Book56.3x
Beta0.22
Balance sheet & cash
Market cap2665.91 Bn€
Total debt29.15 Bn€
Free Cash Flow8.67 Bn€
Debt / Equity72%
Profitability & ownership
ROE23.5%
ROA8.5%
% insiders0.0%
% institutions63.0%
Last declaration on 18 August 2025
Declarations13 total
Executives●Sale30FIN-FSA
€1m9,563 shares@ €115.1170.0000% mcap15.1% of flow
Aktie
FI:A003R490-1·
Executives●Purchase29FIN-FSA
€6m51,737 shares@ €119.630.0002% mcap84.9% of flow
Aktie
FI:A003Q114-1·
Ideal exit: 29 Nov 2025 (T+270)
Executives●Other21FIN-FSA
0200 shares0
Depåbevis
FI:A003Q113-1·
Executives●Other21FIN-FSA
028 shares0
Aktie
FI:A003Q116-1·
Executives●Purchase21FIN-FSA
02,021 shares0
Aktie
FI:A003Q115-1·
Ideal exit: 29 Nov 2025 (T+270)
Executives●Purchase24FIN-FSA
089,962 shares0
Aktie
FI:A003Q112-1·
Ideal exit: 1 Dec 2025 (T+270)
Executives●Purchase24FIN-FSA
017,357 shares0
Aktie
FI:A003Q110-1·
Ideal exit: 29 Nov 2025 (T+270)
Executives●Purchase32FIN-FSA
€15m124,404 shares@ €119.630.0006% mcap83.4% of flow
Aktie
FI:A003Q109-1·
Ideal exit: 29 Nov 2025 (T+270)
Executives●Other24FIN-FSA
0297,418 shares0
Aktie
FI:A003Q108-1·
Executives●Purchase26FIN-FSA
€3m29,474 shares@ €100.810.0001% mcap16.6% of flow
Aktie
FI:A003Q107-1·
Ideal exit: 7 Feb 2025 (T+270)
Executives●Purchase24FIN-FSA
08,970 shares0
Aktie
FI:A003O753-1·
Ideal exit: 15 Feb 2026 (T+270)
Executives●Purchase17FIN-FSA
€100,3171,400 shares@ €71.6550.0000% mcap100.0% of flow
Depåbevis
FI:A003N793-1·
Ideal exit: 25 Jan 2026 (T+270)
13 of 13 declarations